In support of the existence and relevance of RAS dimers in vivo, the expression of an oncogenic KRAS dimerization mutant in transgenic mice resulted in the loss of the tumor suppressor effect of wildtype KRAS, which is thought to be exerted by dimerization [105]. This evidence concerns the gene KRAS and neoplasm.